Main
>
ENDOCRINOLOGY
>
Diabetes. Treatment
>
SaxaGliptin (DPP-IV Inhibitor)
>
Co.: USA. B. Approved/Patents
>
Patent>US Expiration: 02.16.2021
Patent>US Expiration: 02.16.2021's products
This section has no products